Transarterial chemoembolization (TACE) for inoperable intrahepatic cholangiocarcinoma

CardioVascular and Interventional Radiology

Volumn 30, Issue 6, 2007, Pages 1156-1165

  Herber, S ^a   Otto, G ^a   Schneider, J ^a   Manzl, N ^a   Kummer, I ^a   Kanzler, S ^a   Schuchmann, A ^a   Thies, J ^a   Duber C ^a   Pitton, M ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Chemoembolization; Cholangiocarcinoma; Kaplan Meier; Lipiodol; Mitomycin C; Survival; TACE

Indexed keywords

ANALGESIC AGENT; CONTRAST MEDIUM; DIPYRONE; GADOLINIUM; GLYCERYL TRINITRATE; IODINATED POPPYSEED OIL; LIPIODOL ULTRA FLUID; METOCLOPRAMIDE; MITOMYCIN C; OMEPRAZOLE; ONDANSETRON; PARACETAMOL; TROPISETRON; UNCLASSIFIED DRUG;

ADULT; AGED; ANAPHYLACTIC SHOCK; ARTICLE; BILE DUCT CARCINOMA; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; CLINICAL PROTOCOL; FEMALE; FOLLOW UP; HUMAN; INOPERABLE CANCER; MALE; NAUSEA; PAIN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STOMACH ULCER; VOMITING;

AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHEMOEMBOLIZATION, THERAPEUTIC; CHOLANGIOCARCINOMA; CONTRAST MEDIA; FEMALE; HUMANS; IODIZED OIL; IOPAMIDOL; MALE; MIDDLE AGED; MITOMYCIN; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 35848953447     PISSN: 01741551     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00270-007-9032-7     Document Type: Article

References (34)

1. Anderson CD, Pinson CW, Berlin J, et al. (2004) Diagnosis and treatment of cholangiocarcinoma. Oncologist 9(1):43-57
2. Khan S, Howard CT, Davidson BR, et al. (2005) Cholangiocarcinoma. Lancet 366:1303-1314
3. Olnes MJ, Erlich R (2004) A review and update on cholangiocarcinoma. Oncology 66(3):167-179
4. Farley DR, Weaver AL, Nagorney DM (1995) "Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention. Mayo Clin Proc 70(5):425-429
5. Heimbach JK, Gores GJ, Haddock MG, et al. (2004) Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis 24(2):201-207
6. Llovet JM, Real MI, Montana X, et al. Barcelona Liver Cancer Group (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359(9319):1734-1739
7. Lo CM, Ngan H, Tso WK, et al. (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35(5):1164-1171
8. Burger I, Hong K, Schulick R, et al. (2005) Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. J Vasc Interv Radiol 16(3):353-361
9. Huppert PE, Lauchart W, Duda S, et al. (2004) Chemoembolisation des hepatozellulären Karzinoms: Welche Faktoren bestimmen Therapieansprechen und Überleben? Fortschr Röntgenstr 176:375-385
10. Therasse P (2002) Measuring the clinical response. What does it mean? Eur J Cancer 38(14):1817-1823
11. Sacks D, McClenny TE, Cardella JF, et al. (2003) Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 14(9; Pt 2):S199-S202
12. Ikeda M, Okusaka T, Ueno H, Morizane C, Furuse J, Ishii H (2005) A phase II trial of uracil-tegafur (UFT) in patients with advanced biliary tract carcinoma. Jpn J Clin Oncol 35(8):439-443
13. Okusaka T, Ishii H, Funakoshi A, et al. (2006) Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer. Cancer Chemother Pharmacol 57(5):647-653
14. Kornek GV, Schuell B, Laengle F, et al. (2004) Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial. Ann Oncol 15(3):478-483
15. Raderer M, Hejna MH, Valencak JB, et al. (1999) Two consecutive phase II studies of 5-fluorouracil/leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancer. Oncology 56(3):177-180
16. Penz M, Kornek GV, Raderer M, et al. (2001) Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. Ann Oncol 12(2):183-186
17. Marelli L, Stigliano R, Triantos C, et al. (2007) Transarterial therapy for hepatocellular carcinoma: Which technique is more effective? A systematic review of cohort and randomized studies Cardiovasc Intervent Radiol 30(1):6-25
18. Malhi H, Gores GJ (2006) Review article: the modern diagnosis and therapy of cholangiocarcinoma. Aliment Pharmacol Ther 23(9):1287-1296
19. Hejna M, Pruckmayer M, Raderer M (1998) The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. Eur J Cancer 34(7):977-986
20. Todoroki T (2000) Chemotherapy for bile duct carcinoma in the light of adjuvant chemotherapy to surgery. Hepatogastroenterology 47(33):644-649
21. Herber S, Schneider J, Brecher B, et al. (2005) TACE: therapy of the HCC before liver transplantation-experiences. Fortschr Röntgenstr 177(5):681-690 [in German]
22. Otto G, Herber S, Heise M, et al. (2006) Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl 12(8):1260-1267
23. Kirchhoff T, Zender L, Merkesdal S, et al. (2005) Initial experience from a combination of systemic and regional chemotherapy in the treatment of patients with nonresectable cholangiocellular carcinoma in the liver. World J Gastroenterol 11(8):1091-1095
24. Vogl TJ, Schwarz W, Eichler K, et al. (2006) Hepatic intraarterial chemotherapy with gemcitabine in patients with unresectable cholangiocarcinomas and liver metastases of pancreatic cancer: a clinical study on maximum tolerable dose and treatment efficacy. J Cancer Res Clin Oncol 132(11):745-755
25. Tanaka N, Yamakado K, Nakatsuka A, et al. (2002) Arterial chemoinfusion therapy through an implanted port system for patients with unresectable intrahepatic cholangiocarcinoma-initial experience. Eur J Radiol 41(1):42-48
26. Choi BI, Kim HC, Han JK, et al. (1992) Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings. Radiology 182(3):709-713
27. Eurvilaichit C (2004) Outcome of transcatheter oily chemoembolization in patients with hepatocellular carcinoma. Hepatogastroenterology 51(55):20-24
28. Shimada M, Takenaka K, Kawahara N, et al. (1996) Chemosensitivity in primary liver cancers: evaluation of the correlation between chemosensitivity and clinicopathological factors. Hepatogastroenterology 43(11):1159-1164
29. Lee GW, Kang JH, Kim HG, et al. (2006) Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistochemically proven cholangiocarcinoma. Am J Clin Oncol 29(2):127-131
30. Asakura H, Ohtsuka M, Ito H, et al. (2005) Long-term survival after extended surgical resection of intrahepatic cholangiocarcinoma with extensive lymph node metastasis. Hepatogastroenterology 52(63):722-724
31. Heron DE, Stein DE, Eschelman DJ, et al. (2003) Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome. Am J Clin Oncol 26(4):422-428
32. Park SH, Park YH, Lee JN, et al. (2006) Phase II study of epirubicin, cisplatin, and capecitabine for advanced biliary tract adenocarcinomas. Cancer 106(2):361-365
33. Knox JJ, Hedley D, Oza A, et al. (2005) Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. J Clin Oncol 23(10):2332-2338
34. Papakostas P, Kouroussis C, Androulakis, et al. (2001) First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study. Eur J Cancer 37(15):1833-1838